162 related articles for article (PubMed ID: 26567084)
21. Novel NPR2 Gene Mutations Affect Chondrocytes Function via ER Stress in Short Stature.
Li Q; Fan X; Lu W; Sun C; Pei Z; Zhang M; Ni J; Wu J; Yu FX; Luo F
Cells; 2022 Apr; 11(8):. PubMed ID: 35455946
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
Amano N; Mukai T; Ito Y; Narumi S; Tanaka T; Yokoya S; Ogata T; Hasegawa T
J Clin Endocrinol Metab; 2014 Apr; 99(4):E713-8. PubMed ID: 24471569
[TBL] [Abstract][Full Text] [Related]
23. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
[TBL] [Abstract][Full Text] [Related]
24. Further defining the clinical and molecular spectrum of acromesomelic dysplasia type maroteaux: a Turkish tertiary center experience.
Simsek-Kiper PO; Urel-Demir G; Taskiran EZ; Arslan UE; Nur B; Mihci E; Haliloglu M; Alanay Y; Utine GE; Boduroglu K
J Hum Genet; 2021 Jun; 66(6):585-596. PubMed ID: 33288834
[TBL] [Abstract][Full Text] [Related]
25. Identification of one novel homozygous mutation in the NPR2 gene in a patient from Taiwan with acromesomelic dysplasia Maroteaux type.
Lin WD; Wang CH; Tsai FJ
Pediatr Neonatol; 2018 Jun; 59(3):322-323. PubMed ID: 29503224
[No Abstract] [Full Text] [Related]
26. New pathogenic variant in the NPR2 gene: Etiology of low size, macrocephaly and bone dysplasia in a male with acromesomelic dysplasia Maroteaux-type.
Vera Sáez-Benito MC; Izquierdo-Álvarez S; de Arriba Muñoz A
Med Clin (Barc); 2017 Dec; 149(12):553-554. PubMed ID: 28736064
[No Abstract] [Full Text] [Related]
27. A mild case of acromesomelic dysplasia, type Maroteaux with novel natriuretic peptide receptor B (
Murch O; Jain V; Offiah AC
Radiol Case Rep; 2021 Aug; 16(8):2240-2243. PubMed ID: 34178199
[TBL] [Abstract][Full Text] [Related]
28. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.
Vasques GA; Hisado-Oliva A; Funari MF; Lerario AM; Quedas EP; Solberg P; Heath KE; Jorge AA
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):111-116. PubMed ID: 27941173
[TBL] [Abstract][Full Text] [Related]
29. Acromesomelic Dysplasia, Type Maroteaux: Impact of Long-Term (8 Years) High-Dose Growth Hormone Treatment on Growth Velocity and Final Height in 2 Siblings.
Arya VB; Raj M; Younes M; Chapman S; Irving M; Kapoor RR; Buchanan CR
Horm Res Paediatr; 2020; 93(5):335-342. PubMed ID: 33238275
[TBL] [Abstract][Full Text] [Related]
30. Novel mutations in the transmembrane natriuretic peptide receptor NPR-B gene in four Indian families with acromesomelic dysplasia, type Maroteaux.
Srivastava P; Tuteja M; Dalal A; Mandal K; R Phadke S
J Genet; 2016 Dec; 95(4):905-909. PubMed ID: 27994189
[TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics of Short-Stature Patients With an NPR2 Mutation and the Therapeutic Response to rhGH.
Ke X; Liang H; Miao H; Yang H; Wang L; Gong F; Pan H; Zhu H
J Clin Endocrinol Metab; 2021 Jan; 106(2):431-441. PubMed ID: 33205215
[TBL] [Abstract][Full Text] [Related]
32. Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations.
Hwang IT; Mizuno Y; Amano N; Lee HJ; Shim YS; Nam HK; Rhie YJ; Yang S; Lee KH; Hasegawa T; Kang MJ
Mol Genet Genomic Med; 2020 Mar; 8(3):e1146. PubMed ID: 31960617
[TBL] [Abstract][Full Text] [Related]
33. Identification of Diagnostic Variants in
Zhu J; Meng R; Zhao H; Cai L; Wen X; Zeng W; Luo Y; Qi H
DNA Cell Biol; 2022 Nov; 41(11):996-1006. PubMed ID: 36322898
[TBL] [Abstract][Full Text] [Related]
34. Biallelic cGMP-dependent type II protein kinase gene (
Díaz-González F; Wadhwa S; Rodriguez-Zabala M; Kumar S; Aza-Carmona M; Sentchordi-Montané L; Alonso M; Ahmad I; Zahra S; Kumar D; Kushwah N; Shamim U; Sait H; Kapoor S; Roldán B; Nishimura G; Offiah AC; Faruq M; Heath KE
J Med Genet; 2022 Jan; 59(1):28-38. PubMed ID: 33106379
[TBL] [Abstract][Full Text] [Related]
35. Heterozygous
Jacob M; Menon S; Botti C; Marshall I
Case Rep Endocrinol; 2018; 2018():7658496. PubMed ID: 30622824
[TBL] [Abstract][Full Text] [Related]
36. Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.
Shuhaibar LC; Kaci N; Egbert JR; Horville T; Loisay L; Vigone G; Uliasz TF; Dambroise E; Swingle MR; Honkanen RE; Biosse Duplan M; Jaffe LA; Legeai-Mallet L
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986191
[TBL] [Abstract][Full Text] [Related]
37. Heterozygous NPR2 Mutations Cause Disproportionate Short Stature, Similar to Léri-Weill Dyschondrosteosis.
Hisado-Oliva A; Garre-Vázquez AI; Santaolalla-Caballero F; Belinchón A; Barreda-Bonis AC; Vasques GA; Ramirez J; Luzuriaga C; Carlone G; González-Casado I; Benito-Sanz S; Jorge AA; Campos-Barros A; Heath KE
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1133-42. PubMed ID: 26075495
[TBL] [Abstract][Full Text] [Related]
38. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
Tsuji T; Kunieda T
J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
[TBL] [Abstract][Full Text] [Related]
39. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Miura K; Namba N; Fujiwara M; Ohata Y; Ishida H; Kitaoka T; Kubota T; Hirai H; Higuchi C; Tsumaki N; Yoshikawa H; Sakai N; Michigami T; Ozono K
PLoS One; 2012; 7(8):e42180. PubMed ID: 22870295
[TBL] [Abstract][Full Text] [Related]
40. Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH.
Chen H; Zhang S; Sun Y; Chen J; Yuan K; Zhang Y; Yang X; Lin X; Chen R
Orphanet J Rare Dis; 2023 Jul; 18(1):221. PubMed ID: 37501190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
